ED vs EDIT
Consolidated Edison Inc (ED) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
ED currently screens at market cap $36.02B and trailing P/E 18.3. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the ED and EDIT stock pages for the full models.
Not investment advice.